TSC2 and acute myeloid leukemia: Phase contrast images of the TSC2(+) AML cells seeded at low cell density were taken to illustrate that RSL3 treatment caused the cells to round up (Figure 1f), which was prevented with either deferiprone, ferrostatin-1 or necrostatin-1.